Global /United States /Healthcare /Medical Devices /AEMD

Aethlon Medical, Inc.

AEMD

• NASDAQ: AEMD • Delayed

2.13USD -0.9%

As of 13 June 2026, Aethlon Medical, Inc. has a market cap of $3.34M USD, ranking #45834 globally and #5820 in the United States. It ranks #4058 in the Healthcare sector, and #857 in the Medical Devices industry.

Global Rank

45834

Country Rank

5820

Sector Rank

4058

Industry Rank

857

Key Stats

Market Cap

$3.34MUSD

Enterprise Value

-$3.17MUSD

EBITDA (TTM)

-$7.01MUSD

Net Income (TTM)

-$11.52MUSD

PB Ratio

0.3

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Devices

CEO

James Frakes open_in_new

Employees

Founded

1984

Website

aethlonmedical.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.9%	-7%	-0.9%	-20%	-61%	-23%	-93%	-99%	-100%

News

AEMD Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	AEMD ISIN: US00808Y6041 Shares Out.: Shares Outstanding: 2.371M¹ Shares Float: 2.273M² TV: TradingView: NASDAQ: AEMD SA: Stock Analysis: NASDAQ: AEMD YF: Yahoo Finance: AEMD GF: Google Finance: NASDAQ: AEMD NQ: NASDAQ: AEMD BA: Barron's: AEMD MS: Morningstar: XNAS: AEMD	2.13 USD	TV: TradingView: NASDAQ: AEMD SA: Stock Analysis: NASDAQ: AEMD YF: Yahoo Finance: AEMD GF: Google Finance: NASDAQ: AEMD NQ: NASDAQ: AEMD BA: Barron's: AEMD MS: Morningstar: XNAS: AEMD

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Aethlon Medical, Inc.

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Similar Companies

Industry: Medical Devices (United States)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 5M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 5M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 5M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 4M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 4M%	38.3	United States
Boston Scientific Corp. NYSE: BSX	$84.93B 3M%	24.5	United States

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Medtronic plc NYSE: MDT	$101.9B 3M%	22.2	Ireland
EssilorLuxottica Société anonyme EPA: EL	$97.46B 84.32B EUR 3M%	36.7	France
HOYA Corp. TSE: 7741	$61.41B 9.83T JPY 2M%	40.0	Japan
Siemens Healthineers AG XETRA: SHL	$45.47B 39.34B EUR 1M%	18.7	Germany
Alcon Inc. SIX: ALC	$36.38B 28.99B CHF 1M%	37.9	Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 899K%	26.0	China

chevron_leftBack